ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002424 ST百灵

已收盘 11-06 15:00:00

{"stockData":{"symbol":"002424","market":"SZ","secType":"STK","nameCN":"ST百灵","latestPrice":4.43,"timestamp":1793948601000,"preClose":4.47,"halted":0,"volume":5345300,"delay":0,"changeRate":-0.0089,"floatShares":1140000000,"shares":1386000000,"eps":-0.0933,"marketStatus":"已收盘","change":-0.04,"latestTime":"11-06 15:00:00","open":4.42,"high":4.45,"low":4.4,"amount":23683200,"amplitude":0.0112,"askPrice":4.43,"askSize":1092,"bidPrice":4.42,"bidSize":2842,"shortable":0,"etf":0,"ttmEps":-0.0933,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":4.47,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":4.69,"lowLimit":4.25,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1385501500,"isCdr":false,"pbRate":1.94,"roa":"--","roe":"1.01%","epsLYR":-0.08,"committee":0.241635,"marketValue":6138000000,"turnoverRate":0.0047,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-09。","floatMarketCap":5049000000},"requestUrl":"/m/hq/s/002424","defaultTab":"news","newsList":[{"id":"2680759125","title":"ST百灵（002424）披露证券事务代表辞职暨聘任公告，11月02日股价上涨0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680759125","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680759125?lang=zh_cn&edition=full","pubTime":"2026-11-02 19:37","pubTimestamp":1793619437,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘，ST百灵报收于4.48元，较前一交易日上涨0.67%，最新总市值为62.07亿元。公司近日披露《关于证券事务代表辞职暨聘任证券事务代表的公告》。公告显示，贵州百灵企业集团制药股份有限公司董事会于近日收到证券事务代表陈智先生的书面辞职申请，其因个人原因辞去公司证券事务代表职务，辞职后不再担任公司及子公司任何职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200029909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","BK0239","BK0183","BK0188","BK0146","BK0077","002424","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679214126","title":"ST百灵：截至2026年10月20日，公司股东总户数为57430","url":"https://stock-news.laohu8.com/highlight/detail?id=2679214126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679214126?lang=zh_cn&edition=full","pubTime":"2026-10-30 20:52","pubTimestamp":1793364734,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵(002424)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止26.10.21股东人数？谢谢ST百灵回复：感谢您对公司的关注。截至2026年10月20日，公司股东总户数为57430。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000054201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0077","BK0188","002424","BK0239","BK0028","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678319011","title":"股市必读：ST百灵三季报 - 第三季度单季净利润同比下降61.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678319011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678319011?lang=zh_cn&edition=full","pubTime":"2026-10-26 06:27","pubTimestamp":1792967230,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年前三季度归母净利润3193.8万元，同比下降43.79%；第三季度单季归母净利润191.01万元，同比下降61.64%。公司公告汇总：第六届董事会第三十一次会议于10月23日审议通过《2026年第三季度报告》，8名董事全票通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678183185","title":"ST百灵（002424）2026年三季报简析：净利润同比下降43.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678183185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678183185?lang=zh_cn&edition=full","pubTime":"2026-10-25 06:07","pubTimestamp":1792879679,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期ST百灵发布2026年三季报。根据财报显示，ST百灵净利润同比下降43.79%。截至本报告期末，公司营业总收入14.12亿元，同比下降32.83%，归母净利润3193.8万元，同比下降43.79%。按单季度数据看，第三季度营业总收入4.41亿元，同比下降31.04%，第三季度归母净利润191.01万元，同比下降61.64%。财报体检工具显示：建议关注公司现金流状况本文数据来源于ST百灵2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102500000557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677904790","title":"ST百灵(002424)10月9日股东户数5.77万户，较上期减少2.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677904790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677904790?lang=zh_cn&edition=full","pubTime":"2026-10-24 17:10","pubTimestamp":1792833017,"startTime":"0","endTime":"0","summary":"证券之星消息，近日ST百灵披露，截至2026年10月9日公司股东户数为5.77万户，较9月30日减少1303.0户，减幅为2.21%。在中药行业个股中，ST百灵股东户数高于行业平均水平，截至10月9日，中药行业平均股东户数为5.27万户。从股价来看，2026年9月30日至2026年10月9日，ST百灵区间跌幅为1.71%，在此期间股东户数减少1303.0户，减幅为2.21%。根据统计，ST百灵2026年9月30日至2026年10月9日，主力资金净流出596.24万元，游资资金净流入380.47万元，散户资金净流入215.77万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400014119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0239","BK0028","BK0146","BK0077","BK0183","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677971586","title":"图解ST百灵三季报：第三季度单季净利润同比下降61.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677971586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677971586?lang=zh_cn&edition=full","pubTime":"2026-10-24 01:30","pubTimestamp":1792776634,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵2026年三季报显示，前三季度公司主营收入14.12亿元，同比下降32.83%；归母净利润3193.8万元，同比下降43.79%；扣非净利润3420.15万元，同比上升61.25%；其中2026年第三季度，公司单季度主营收入4.41亿元，同比下降31.04%；单季度归母净利润191.01万元，同比下降61.64%；单季度扣非净利润650.91万元，同比下降11.61%；负债率43.05%，投资收益-3607.54万元，财务费用3720.41万元，毛利率40.59%。财报数据概要请见下图:本文数据来源于ST百灵2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400002368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677692207","title":"ST百灵：同意糖宁通络乳膏开展Ⅱ期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2677692207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677692207?lang=zh_cn&edition=full","pubTime":"2026-10-23 20:51","pubTimestamp":1792759910,"startTime":"0","endTime":"0","summary":"公司全资子公司百灵毓秀（珠海）医药有限公司于2026年9月收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意糖宁通络乳膏在进一步完善临床试验方案的基础上开展用于糖尿病足溃疡的Ⅱ期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300042262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0183","BK0146","BK0239","BK0077","002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677092270","title":"ST百灵：银丹心脑通软胶囊、护肝片、强力枇杷露中选全国中成药采购联盟集中带量采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2677092270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677092270?lang=zh_cn&edition=full","pubTime":"2026-10-23 20:51","pubTimestamp":1792759902,"startTime":"0","endTime":"0","summary":"公司产品银丹心脑通软胶囊、护肝片、强力枇杷露中选全国中成药采购联盟集中带量采购，中选结果由湖北省医疗保障局于2026年6月17日公布，公司已于2026年6月披露《关于公司产品中选全国中成药采购联盟集中带量采购的公告》。中选产品的采购周期、供应保障等事项按照联采办公室公布的中选结果及各地执行文件执行，具体执行进度请以各省级医药集中采购平台公布的实施安排为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300042252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","002424","BK0239","BK0183","BK0188","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677922777","title":"ST百灵：截至2026年10月09日，公司股东总户数为57681","url":"https://stock-news.laohu8.com/highlight/detail?id=2677922777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677922777?lang=zh_cn&edition=full","pubTime":"2026-10-23 20:51","pubTimestamp":1792759883,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵(002424)10月22日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问一下现在股东人数多少ST百灵回复：感谢您对公司的关注。截至2026年10月09日，公司股东总户数为57681。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300042236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0183","BK0077","BK0188","BK0239","002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677966359","title":"股市必读：ST百灵新发布《关于完成工商变更登记并换发营业执照的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677966359","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677966359?lang=zh_cn&edition=full","pubTime":"2026-10-23 04:00","pubTimestamp":1792699237,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘，ST百灵报收于4.61元，上涨0.22%，换手率0.46%，成交量5.26万手，成交额2418.45万元。当日关注点交易信息汇总：10月22日主力资金净流入211.3万元，占总成交额8.74%。公司公告汇总：公司已完成回购股份注销及工商变更登记，注册资本由1,397,598,400元减少至1,385,501,500元，并取得换发营业执照。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0239","BK0028","BK0146","BK0077","BK0183","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677393445","title":"四年年报财务造假，ST百灵索赔已有实质进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2677393445","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677393445?lang=zh_cn&edition=full","pubTime":"2026-10-22 15:15","pubTimestamp":1792653300,"startTime":"0","endTime":"0","summary":"2026年3月27日，处罚决定书正式落地。监管表态称，财务造假是严重破坏市场“三公”原则、侵害投资者合法权益的毒瘤，将坚持“零容忍”打击。值得一提的是，投资者索赔已有实质进展：刘佳律师表示，已向贵阳中院提交受损投资者索赔立案材料，且已有案件审查通过，正等待法院的进一步审理。基本面方面，2025年公司实现营业收入30.49亿元，同比下降20.31%；归母净利润亏损1.04亿元，同比下降410.41%，业绩基本面尚未走出造假阴霾。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2026-10-22/doc-iniwarrs4925656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","002424","BK0188","BK0146","BK0183","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677703876","title":"ST百灵（002424）披露完成工商变更登记并换发营业执照公告，10月21日股价上涨1.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677703876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677703876?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:23","pubTimestamp":1792592597,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘，ST百灵报收于4.6元，较前一交易日上涨1.55%，最新总市值为63.73亿元。公司近日发布《关于完成工商变更登记并换发营业执照的公告》。公告显示，贵州百灵企业集团制药股份有限公司于2026年6月16日和7月2日分别召开第六届董事会第二十八次会议及2026年第四次临时股东会，审议通过变更回购股份用途并注销、减少注册资本及修订《公司章程》的议案。公司已回购的12,096,900股股份用于注销，注册资本由1,397,598,400元减少至1,385,501,500元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0146","BK0188","BK0028","BK0239","BK0077","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671429194","title":"ST百灵（002424）9月29日主力资金净买入59.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671429194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671429194?lang=zh_cn&edition=full","pubTime":"2026-09-29 15:36","pubTimestamp":1790667389,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，ST百灵报收于4.63元，下跌1.7%，换手率0.87%，成交量9.87万手，成交额4624.96万元。9月29日的资金流向数据方面，主力资金净流入59.38万元，占总成交额1.28%，游资资金净流出5.28万元，占总成交额0.11%，散户资金净流出54.1万元，占总成交额1.17%。ST百灵主营业务：集苗药研发、生产、销售于一体的医药上市公司。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900020588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002424","BK0188","BK0146","BK0183","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235608","title":"ST百灵(002424)9月10日股东户数5.8万户，较上期减少0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670235608?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:50","pubTimestamp":1790589041,"startTime":"0","endTime":"0","summary":"证券之星消息，近日ST百灵披露，截至2026年9月10日公司股东户数为5.8万户，较8月10日减少471.0户，减幅为0.81%。在中药行业个股中，ST百灵股东户数高于行业平均水平，截至9月10日，中药行业平均股东户数为5.22万户。从股价来看，2026年8月10日至2026年9月10日，ST百灵区间涨幅为0.65%，在此期间股东户数减少471.0户，减幅为0.81%。根据统计，ST百灵2026年8月10日至2026年9月10日，主力资金净流出5058.73万元，游资资金净流入2343.59万元，散户资金净流入2715.14万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800023378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0077","BK0239","BK0183","002424","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670282802","title":"ST百灵（002424）9月28日主力资金净买入132.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670282802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670282802?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:29","pubTimestamp":1790580557,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，ST百灵报收于4.71元，上涨2.17%，换手率1.05%，成交量12.0万手，成交额5556.39万元。9月28日的资金流向数据方面，主力资金净流入132.44万元，占总成交额2.38%，游资资金净流出190.65万元，占总成交额3.43%，散户资金净流入58.21万元，占总成交额1.05%。ST百灵主营业务：集苗药研发、生产、销售于一体的医药上市公司。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","BK0146","BK0183","BK0077","002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409782","title":"股市必读：ST百灵新发布《关于获得发明专利证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409782","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409782?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:23","pubTimestamp":1790533391,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，ST百灵报收于4.61元，上涨3.83%，换手率1.96%，成交量22.39万手，成交额1.04亿元。当日关注点交易信息汇总：9月24日主力资金净流入504.7万元，占总成交额4.85%。公司公告汇总：ST百灵于9月23日公告获得发明专利证书，专利名称为“一种治疗糖尿病或其并发症的中药制剂”，专利号ZL202610042695.2，授权公告日为2026年9月18日。该专利为保密发明专利，技术内容未予公开。专利权人为贵州百灵企业集团制药股份有限公司，发明人为姜伟。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0077","BK0188","002424","BK0239","BK0028","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669810450","title":"ST百灵（002424）9月24日主力资金净买入504.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669810450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669810450?lang=zh_cn&edition=full","pubTime":"2026-09-24 15:29","pubTimestamp":1790234956,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，ST百灵报收于4.61元，上涨3.83%，换手率1.96%，成交量22.39万手，成交额1.04亿元。9月24日的资金流向数据方面，主力资金净流入504.7万元，占总成交额4.85%，游资资金净流入44.62万元，占总成交额0.43%，散户资金净流出549.32万元，占总成交额5.28%。ST百灵主营业务：集苗药研发、生产、销售于一体的医药上市公司。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400021648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0146","BK0183","BK0239","BK0077","BK0188","002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438989","title":"股市必读：ST百灵新发布《关于获得发明专利证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669438989?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:22","pubTimestamp":1790184132,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，ST百灵报收于4.44元，下跌1.77%，换手率0.7%，成交量7.99万手，成交额3571.43万元。当日关注点交易信息汇总：9月23日主力资金净流出1118.69万元，占总成交额31.33%。公司公告汇总：ST百灵于9月23日公告获得发明专利证书，专利名称为“一种治疗糖尿病或其并发症的中药制剂”，专利号ZL202610042695.2，授权公告日为2026年9月18日。该专利为保密发明专利，技术内容未予公开。专利权人为贵州百灵企业集团制药股份有限公司，发明人为姜伟。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400001996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0077","BK0188","002424","BK0239","BK0028","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668252199","title":"ST百灵：关于黄连解毒丸项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2668252199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668252199?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:48","pubTimestamp":1789735710,"startTime":"0","endTime":"0","summary":"那个子公司和仁堂20%股份购买后十年不过户，重组人内皮抑素注射液项目纠纷也多年未解决，黄连解毒丸项目3期临床结束都2年多了还没看到上市申请…谢谢ST百灵回复：感谢您对公司长期关注以及所提的宝贵建议，公司已收悉并将转相关部门。公司将持续关注并依法依规推进该事项的后续办理工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800034938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0146","BK0188","BK0028","BK0239","BK0077","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668252919","title":"ST百灵：截止2026年9月10日，公司股东总户数为58,013","url":"https://stock-news.laohu8.com/highlight/detail?id=2668252919","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668252919?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:48","pubTimestamp":1789735705,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵(002424)09月18日在投资者关系平台上答复投资者关心的问题。投资者提问：股东人数多少？ST百灵回复：感谢您对公司的关注。截止2026年9月10日，公司股东总户数为58,013。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800034932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0183","BK0188","BK0146","BK0077","002424","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794019648355,"stockEarnings":[{"period":"1week","weight":-0.0045},{"period":"1month","weight":-0.0554},{"period":"3month","weight":-0.0349},{"period":"6month","weight":-0.1087},{"period":"1year","weight":-0.2388},{"period":"ytd","weight":0.0184}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州百灵企业集团制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"57430人(较上一季度减少0.44%)","perCapita":"19846股","listingDate":"2010-06-03","address":"贵州省安顺市西秀区经济技术开发区西航路212号","registeredCapital":"138550万元","survey":"　　贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的主要产品是银丹心脑通软胶囊、咳速停糖浆/胶囊、复方一枝黄花喷雾剂、维C银翘片、小儿柴桂退热颗粒、强力枇杷露、双羊喉痹通颗粒。公司获得了贵州省医药产业骨干企业、全国最大的苗药研制生产企业、2025中国医药市场药企排行榜（中药）TOP100第28位、2026中药研发实力TOP50榜单、第二届“长高赛”最佳商业化潜力奖。","listedPrice":40},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST百灵,002424,ST百灵股票,ST百灵股票老虎,ST百灵股票老虎国际,ST百灵行情,ST百灵股票行情,ST百灵股价,ST百灵股市,ST百灵股票价格,ST百灵股票交易,ST百灵股票购买,ST百灵股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}